![Patent term extension systems differentiate Japanese and US drug lifecycle management - ScienceDirect Patent term extension systems differentiate Japanese and US drug lifecycle management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644615003451-gr1.jpg)
Patent term extension systems differentiate Japanese and US drug lifecycle management - ScienceDirect
![Japan: Court addresses foreign clinical trial periods and patent term extension | Managing Intellectual Property Japan: Court addresses foreign clinical trial periods and patent term extension | Managing Intellectual Property](https://assets.euromoneydigital.com/dims4/default/417e633/2147483647/strip/true/crop/450x219+0+0/resize/800x389!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F24%2F04%2Ff55f9c86db7a5aea7553c6658c41%2Fchart.jpg)
Japan: Court addresses foreign clinical trial periods and patent term extension | Managing Intellectual Property
![Japan seeks patent term extension at Regional Comprehensive Economic Partnership - The Economic Times Japan seeks patent term extension at Regional Comprehensive Economic Partnership - The Economic Times](https://img.etimg.com/thumb/width-640,height-480,imgsize-93664,resizemode-75,msid-45379577/news/economy/foreign-trade/japan-seeks-patent-term-extension-at-regional-comprehensive-economic-partnership.jpg)
Japan seeks patent term extension at Regional Comprehensive Economic Partnership - The Economic Times
![Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst](https://www.future-science.com/cms/10.4155/ppa.12.80/asset/images/medium/figure2.gif)
Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst
Patent term extensions for biologic innovators in Japan: the Japanese Intellectual Property High Court recently issued two decisions that bolster the market exclusivity period for brand biologic manufacturers - Document - Gale
![Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst](https://www.future-science.com/cms/10.4155/ppa.2013.2.issue-1/asset/17b3443d-6b17-3443-46b1-b3443d46b17b/cover.jpg)
Patent term extension in Japan: challenges still lay ahead even after the 2011 revision | Pharmaceutical Patent Analyst
![Is it worth filing patent term extension in Japan when expected patent term extension is only a few weeks or even a few days? | TOKYO ACTi International Patent and Trademark Office Is it worth filing patent term extension in Japan when expected patent term extension is only a few weeks or even a few days? | TOKYO ACTi International Patent and Trademark Office](https://tokyo-acti.com/en/wp-content/uploads/2015/09/Fotolia_90785872_XS1-300x225.jpg)
Is it worth filing patent term extension in Japan when expected patent term extension is only a few weeks or even a few days? | TOKYO ACTi International Patent and Trademark Office
![Supplementary Protection Certificates – European Patent Term Extensions - Life Sciences, Biotechnology & Nanotechnology - United States Supplementary Protection Certificates – European Patent Term Extensions - Life Sciences, Biotechnology & Nanotechnology - United States](https://www.mondaq.com/images/article_images/1234982a.jpg)
Supplementary Protection Certificates – European Patent Term Extensions - Life Sciences, Biotechnology & Nanotechnology - United States
![Patent Term Extension and the Active Ingredient Problem - NYU Journal of Intellectual Property & Entertainment Law Patent Term Extension and the Active Ingredient Problem - NYU Journal of Intellectual Property & Entertainment Law](https://jipel.law.nyu.edu/wp-content/uploads/2020/05/image001-1.png)
Patent Term Extension and the Active Ingredient Problem - NYU Journal of Intellectual Property & Entertainment Law
![New Ruling on Scope of Protection of Extended Patent Rights in JAPAN – Japanese Patent Attorneys | Allegro IP New Ruling on Scope of Protection of Extended Patent Rights in JAPAN – Japanese Patent Attorneys | Allegro IP](https://allegropat.com/wp-content/uploads/2019/05/US-and-JP-practices.jpg)
New Ruling on Scope of Protection of Extended Patent Rights in JAPAN – Japanese Patent Attorneys | Allegro IP
![Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm](https://www.finnegan.com/a/web/247374/2G4HEu/pf4.png)
Reclaiming Their Time: Patent Term Adjustment (PTA) and Patent Term Extension (PTE) Post Supernus, Novartis I, and Novartis II | Finnegan | Leading IP+ Law Firm
![Recent Federal Circuit Decisions on Obviousness-Type Double Patenting May Shape Life Science Patent Portfolio Management | Dechert LLP - JDSupra Recent Federal Circuit Decisions on Obviousness-Type Double Patenting May Shape Life Science Patent Portfolio Management | Dechert LLP - JDSupra](https://jdsupra-html-images.s3-us-west-1.amazonaws.com/08e710c8-b64b-41cd-88a1-0463c1401cee-image4.png)
Recent Federal Circuit Decisions on Obviousness-Type Double Patenting May Shape Life Science Patent Portfolio Management | Dechert LLP - JDSupra
![Patent term extension systems differentiate Japanese and US drug lifecycle management - ScienceDirect Patent term extension systems differentiate Japanese and US drug lifecycle management - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644615003451-gr3.jpg)